NCT05811754View on ClinicalTrials.gov

Safety of Herpes Zoster Subunit (HZ/su) Vaccine During Pregnancy in Adult Women With Immunocompromised Conditions

Not yet recruitingOBSERVATIONAL

Enrollment

2,844

Participants

Timeline

Start Date

April 3, 2023

Primary Completion Date

May 31, 2028

Study Completion Date

April 30, 2029

Conditions

Herpes Zoster

Interventions

OTHER

Data collection

"This study will be conducted using data provided by U.S. Data Partners in the FDA's Sentinel System.~Three Data Partners will participate in this study: CVS Health Clinical Trial Services (CTS), HealthCore, Inc., and Optum."